Literature DB >> 31631991

Risk Factors And Epigenetic Markers Of Left Ventricular Diastolic Dysfunction With Preserved Ejection Fraction In A Community-Based Elderly Chinese Population.

Wei Wang1,2, Yi Zhang3, Runzi Wang1,2, Yeshaswi Shrestha1,2, Yawei Xu3, Luying Peng1,4,5, Jie Zhang1,2, Jue Li1,2, Lijuan Zhang1,2.   

Abstract

PURPOSE: Left ventricular diastolic dysfunction with preserved ejection fraction (LVDD-PEF) is an early-stage manifestation but poorly understood in the process of heart failure. This study was designed to investigate risk factors and epigenetic markers for predicting LVDD-PEF. PATIENTS AND METHODS: A community-based study in 1568 residents over 65 years was conducted in Shanghai, People's Republic of China, from June 2014 to August 2015. Echocardiography was performed to diagnose LVDD-PEF. DNA methylation by whole-genome bisulfite sequencing was used to determine those potential epigenetic markers contributing to LVDD-PEF.
RESULTS: A total of 177 participants (11.3%) were diagnosed with LVDD-PEF, and higher prevalence in females than in males (15.0% vs 6.5%, P<0.001). Multivariate logistic regression analysis indicated that female sex (OR 2.46, 95% CI 1.47-4.13), body mass index (BMI) (OR 1.09, 95% CI 1.04-1.14), pulse pressure (PP) (OR 1.03, 95% CI 1.01-1.05) and carotid intima-media thickness (CIMT) (OR 4.20, 95% CI 1.40-12.55) showed a significant association with LVDD-PEF. Overall, 638 CpG sites were differentially methylated in LVDD-PEF group compared to non-LVDD-PEF group (P<0.001); 242 sites were significantly hypermethylated (covering 238 genes) and 396 sites were significantly hypomethylated (covering 265 genes).
CONCLUSION: Our findings found female, BMI, PP, and CIMT were independent predictors for LVDD-PEF in the community-dwelling elderly population. Regulation of DNA methylation might play a crucial role for LVDD-PEF.
© 2019 Wang et al.

Entities:  

Keywords:  DNA methylation; left ventricular diastolic dysfunction; risk factor

Mesh:

Year:  2019        PMID: 31631991      PMCID: PMC6782027          DOI: 10.2147/CIA.S219748

Source DB:  PubMed          Journal:  Clin Interv Aging        ISSN: 1176-9092            Impact factor:   4.458


  39 in total

1.  Predictors of Development of Echocardiographic Left Ventricular Diastolic Dysfunction in the Subjects Aged 40 to 59 Years (from the Oulu Project Elucidating Risk of Atherosclerosis Study).

Authors:  Juha S Perkiömäki; Mikko Möttönen; Jarmo Lumme; Y Antero Kesäniemi; Olavi Ukkola; Heikki V Huikuri
Journal:  Am J Cardiol       Date:  2015-08-14       Impact factor: 2.778

2.  Impact of progression of diastolic dysfunction on mortality in patients with normal ejection fraction.

Authors:  Wael Aljaroudi; M Chadi Alraies; Carmel Halley; Leonardo Rodriguez; Richard A Grimm; James D Thomas; Wael A Jaber
Journal:  Circulation       Date:  2012-01-18       Impact factor: 29.690

3.  Absence of Rgs5 prolongs cardiac repolarization and predisposes to ventricular tachyarrhythmia in mice.

Authors:  Mu Qin; He Huang; Teng Wang; He Hu; Yu Liu; Hong Cao; Hongliang Li; Congxin Huang
Journal:  J Mol Cell Cardiol       Date:  2012-10-16       Impact factor: 5.000

Review 4.  Developing therapies for heart failure with preserved ejection fraction: current state and future directions.

Authors:  Javed Butler; Gregg C Fonarow; Michael R Zile; Carolyn S Lam; Lothar Roessig; Erik B Schelbert; Sanjiv J Shah; Ali Ahmed; Robert O Bonow; John G F Cleland; Robert J Cody; Ovidiu Chioncel; Sean P Collins; Preston Dunnmon; Gerasimos Filippatos; Martin P Lefkowitz; Catherine N Marti; John J McMurray; Frank Misselwitz; Savina Nodari; Christopher O'Connor; Marc A Pfeffer; Burkert Pieske; Bertram Pitt; Giuseppe Rosano; Hani N Sabbah; Michele Senni; Scott D Solomon; Norman Stockbridge; John R Teerlink; Vasiliki V Georgiopoulou; Mihai Gheorghiade
Journal:  JACC Heart Fail       Date:  2014-04       Impact factor: 12.035

5.  Prevention of heart failure: a scientific statement from the American Heart Association Councils on Epidemiology and Prevention, Clinical Cardiology, Cardiovascular Nursing, and High Blood Pressure Research; Quality of Care and Outcomes Research Interdisciplinary Working Group; and Functional Genomics and Translational Biology Interdisciplinary Working Group.

Authors:  Douglas D Schocken; Emelia J Benjamin; Gregg C Fonarow; Harlan M Krumholz; Daniel Levy; George A Mensah; Jagat Narula; Eileen Stuart Shor; James B Young; Yuling Hong
Journal:  Circulation       Date:  2008-04-07       Impact factor: 29.690

Review 6.  Epigenetic mechanisms in heart failure pathogenesis.

Authors:  Thomas G Di Salvo; Saptarsi M Haldar
Journal:  Circ Heart Fail       Date:  2014-09       Impact factor: 8.790

7.  Inhibition of DNA methylation reverses norepinephrine-induced cardiac hypertrophy in rats.

Authors:  Daliao Xiao; Chiranjib Dasgupta; Man Chen; Kangling Zhang; John Buchholz; Zhice Xu; Lubo Zhang
Journal:  Cardiovasc Res       Date:  2013-11-23       Impact factor: 10.787

8.  BSMAP: whole genome bisulfite sequence MAPping program.

Authors:  Yuanxin Xi; Wei Li
Journal:  BMC Bioinformatics       Date:  2009-07-27       Impact factor: 3.169

9.  Cardiac structure and function in relation to cardiovascular risk factors in Chinese.

Authors:  Yi Zhang; Yan Li; Ming Liu; Chang-Sheng Sheng; Qi-Fang Huang; Ji-Guang Wang
Journal:  BMC Cardiovasc Disord       Date:  2012-10-04       Impact factor: 2.298

Review 10.  Epigenetics in heart failure phenotypes.

Authors:  Alexander Berezin
Journal:  BBA Clin       Date:  2016-05-30
View more
  2 in total

Review 1.  Targeting Age-Related Pathways in Heart Failure.

Authors:  Haobo Li; Margaret H Hastings; James Rhee; Lena E Trager; Jason D Roh; Anthony Rosenzweig
Journal:  Circ Res       Date:  2020-02-13       Impact factor: 17.367

Review 2.  Extracellular Endothelial Cell-Derived Vesicles: Emerging Role in Cardiac and Vascular Remodeling in Heart Failure.

Authors:  Alexander E Berezin; Alexander A Berezin
Journal:  Front Cardiovasc Med       Date:  2020-04-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.